Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
360.8500 0.40 (0.11%)
NSE Oct 28, 2025 10:03 AM
Volume: 180.0K
 

logo
Biocon Ltd.
17 Sep 2021
360.85
0.11%
Serum-Biocon alliance to make India a global vaccine manufacturing powerhouse: SII
Serum-Biocon alliance to make India a global vaccine manufacturing powerhouse: SII
livemint
Biocon Biologics Limited, a subsidiary of Biocon, on Thursday announced a strategic alliance with Serum Institute Life Sciences, a subsidiary of SII
Biocon Ltd. has an average target of 354.40 from 5 brokers.
Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
NDTV Profit | 17 Sep 2021 4 more
More from Biocon Ltd.
Recommended
Market opens flat, Indus Towers' Q2FY26 net profit beats Forecaster estimates by 5.6%
Trendlyne Marketwatch | 28 Oct 2025, 10:04AM
IPO market gains steam: Lenskart headlines this week's mainboard offerings
| 27 Oct 2025, 05:51PM
A long drawn out R&D plan may be finally paying off for Biocon
| 20 Aug 2020